Compared with Group D, we found an enormous elevation in both CD8+ T cell and CD4+ T cell fractions of distal tumor and spleen in Group E, suggesting that RENPs relieved immune tolerance and promoted an effective antitumor immune response (Figure 5H,I). The gene discussed is CD4; the disease is neoplasm.